Navigation Links
Jazz Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Results
Date:3/7/2011

lion -- Xyrem

$ 200 – 210 million-- Luvox CR

$ 32 – 35 million-- Gross margin

greater than 90%-- R&D expenses

$ 20 – 24 million-- SG&A expenses

$ 87 - 93 million-- GAAP net income per diluted share

$ 2.22 – 2.41-- Adjusted net income per diluted share*

$ 2.70 – 2.90 *  A reconciliation of GAAP net income to adjusted net income and the related per diluted share amounts is available in a table with this press release.Conference Call DetailsJazz Pharmaceuticals will host an investor conference call and live audio webcast today at 1:30 p.m. PT/4:30 p.m. ET to provide a business update and discuss 2010 financial results and 2011 financial guidance.  The live webcast may be accessed from the Investors section of the Jazz Pharmaceuticals website at www.JazzPharmaceuticals.com.  Please connect to the website prior to the start of the conference call to ensure adequate time for any software downloads that may be necessary.  Investors may participate in the conference call by dialing 1-866-362-4829 in the U.S., or 1-617-597-5346 outside the U.S., and entering passcode 60782035.

An archived version of the webcast will be available for at least one week on the investors section of the Jazz Pharmaceuticals' website at www.JazzPharmaceuticals.com.

About Jazz Pharmaceuticals, Inc.Jazz Pharmaceuticals is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry.  For further information see www.JazzPharmaceuticals.com.

Non-GAAP Financial MeasuresTo supplement our financial results and financial guidance presented on a GAAP basis, we use the non-GAAP measures adjusted net income/(loss) and ad
'/>"/>

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... FORT WORTH, Texas , Jan. 15, 2014  Humberto ... in Dermatology Achievement Award" from the Journal of ... Dermatology Aesthetic & Clinical Conference (ODAC). The event is January ... Florida . The ...
(Date:1/15/2014)... , Jan. 15, 2014  In an unprecedented effort to curb ... in ambulances and other transport vehicles, an advanced and portable UV ... personnel for the first time. In order to ... these deadly pathogens, West Palm Beach Fire ...
(Date:1/15/2014)... , Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... developing its Symphony® CGM System as a non-invasive, wireless ... F. Doman , Executive Chairman and Interim CEO of ... Markets, Tenth Annual Equity Conference. Mr. ...
Breaking Medicine Technology:Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Superbugs No Longer Ride In Rescue Vehicles 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3
... Aug. 30 The rate of electronic health record ... the next two to five years due to a ... provided by the U.S. government,s HITECH program have also ... (Logo:   http://photos.prnewswire.com/prnh/20081117/FSLOGO ) (Logo:   http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ...
... Memorial Hospital—a not-for-profit, 108-bed hospital in Eden, N.C.—has ... through real-time clinical surveillance and instant access to ... award-winning mobile data system, gathers clinical data from ... patient data to any caregiver at the point-of ...
Cached Medicine Technology:U.S. Ambulatory Electronic Health Record Market Presents Significant Opportunities and Risks for Vendors, Finds Frost & Sullivan 2U.S. Ambulatory Electronic Health Record Market Presents Significant Opportunities and Risks for Vendors, Finds Frost & Sullivan 3Morehead Memorial Hospital Goes Live with Thomson Reuters Clinical Xpert CareFocus 2
(Date:4/24/2014)... and health maps at a fine scale across England ... Area Health Statistics Unit (SAHSU), part of the MRC-PHE ... London, the open-access atlas allows researchers, policy makers and ... of 14 diseases and conditions such as lung cancer, ... Alongside this it provides maps of geographical variations of ...
(Date:4/24/2014)... Orange, NJ. April 24, 2014. Nancy Chiaravalloti, PhD, ... by Saint Peter,s University in Jersey City, New Jersey. ... University,s Pope Lecture Hall on the topic of "Treating ... "It is an honor to be a part of ... Saint Peter,s University," said Dr. Chiaravalloti. "The field of ...
(Date:4/24/2014)... since it was first identified more than 15 years ... an integral role in preventing the onset and progression ... or mutated, malignant cells can grow unchecked and cancer ... at Beth Israel Deaconess Medical Center (BIDMC) helps explain ... how its loss or alteration can set cells on ...
(Date:4/24/2014)... giving scientists a better understanding of drug interactions, which ... , When two or more medications are taken ... the effectiveness of the other. Similarly, one drug ... interactions are a major cause of illness and hospitalization. ... practical scope of drug studies in humans. Limits ...
(Date:4/24/2014)... often coexist with the negative and stressful outcomes for ... diagnosed with a life-limiting illness, says a recent study ... , While the challenges are numerous and life-changing and ... participated in the Waterloo-led research reported positive outcomes as ... appear in the most recent issue of the ...
Breaking Medicine News(10 mins):Health News:New high-detail atlas offers tool to explore local environment and health 2Health News:New high-detail atlas offers tool to explore local environment and health 3Health News:Kessler Foundation scientist named 63rd Mendel Lecturer by St. Peter's University 2Health News:Surprising new insights into the PTEN tumor suppressor gene 2Health News:Surprising new insights into the PTEN tumor suppressor gene 3Health News:Large-scale identification and analysis of suppressive drug interactions 2Health News:Parents of severely ill children see benefits as caregivers, says study 2
... officials desire quick-response emergency capability to treat ... suspected and known cyanide poisoning ... today announced that the,Florida Department of Health, Office of ... for Cyanide,Poisoning in the State,s emergency medical service (EMS) ...
... Physiology and Exercise Metabolism (Montana WPEM) will present a ... American College of Sports Medicine, showing that wildland ... supplement, Wellmune WGP, had far fewer 23 ... similar group of firefighters taking a placebo. , Montana ...
... Italy, 29 May 2008 - Patients suffering from hemineglect ... to their left side. However, sometimes these ignored stimuli ... in the May 2008 issue of Cortex, Jerome Sackur ... reported that unconscious processing in hemineglect is not limited ...
... Amerifit Brands Educates Consumers about Urinary Health, CROMWELL, Conn., ... tract infections (UTIs) are the second most common type,of infection ... doctor visits,each year. One-third of women will be diagnosed with ... women will get at least one in their lifetime.(2),However, many ...
... BOSTON, May 29 The Global Business and ... senior business,executives and clinical scientific leaders, will host a ... The forum is the third,in a series of four ... well being of employees and their families., The ...
... beer, liquor had opposite effect , , THURSDAY, May 29 ... may not only be safe for the liver, but ... disease (NAFLD), according to a new study that challenges ... the University of California, San Diego, included 7,211 nondrinkers ...
Cached Medicine News:Health News:Florida EMS and Fire Vehicles to Stock Cyanokit(R) 5g (hydroxocobalamin for injection) ANTIDOTE ("Cyanokit") for Cyanide Poisoning 2Health News:Florida EMS and Fire Vehicles to Stock Cyanokit(R) 5g (hydroxocobalamin for injection) ANTIDOTE ("Cyanokit") for Cyanide Poisoning 3Health News:Montana Center for Work Physiology and Exercise Metabolism presents firefighter health study 2Health News:AZO Answers the Burning Question: What's Up Down There? 2Health News:AZO Answers the Burning Question: What's Up Down There? 3Health News:AZO Answers the Burning Question: What's Up Down There? 4Health News:Mental Health & Addiction Among Working Parents & Children Affects the Bottom Line: Research Shows Staggering Economic Impact 2Health News:Mental Health & Addiction Among Working Parents & Children Affects the Bottom Line: Research Shows Staggering Economic Impact 3Health News:Mental Health & Addiction Among Working Parents & Children Affects the Bottom Line: Research Shows Staggering Economic Impact 4Health News:Daily Glass of Wine Cut Risk of Fatty Liver Disease 2
... Multi frequency and multigate ... detection and fitted with ... tests for hemodynamic evaluation. ... as well for routine ...
The Spencer Technologies PMD 100 (TCD 100M) is the worlds first stand-alone digital transcranial doppler system....
Swiss Watchmaker Forceps, 4" extra-long precision ground points....
The vertebral body replacement (VBR) is used for the anterior thoracic and lumbar spine. It is intended for use in the thoracic and lumbar spine to replace a collapsed, damaged, or unstable vertebral...
Medicine Products: